The OxyPLEASURE Study - Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency (Central Diabetes Insipidus) and Healthy Controls - a Double-blind Randomized Placebo-controlled Crossover Trial
Latest Information Update: 02 May 2025
At a glance
- Drugs Oxytocin (Primary)
- Indications Sexual function disorders
- Focus Therapeutic Use
- Acronyms OxyPLEASURE
Most Recent Events
- 23 Apr 2025 Planned initiation date changed from 1 Apr 2025 to 1 May 2025.
- 18 Mar 2025 Planned initiation date changed from 1 Feb 2025 to 1 Apr 2025.
- 11 Feb 2025 New trial record